Catestatin Exerts Direct Protective Effects on Rat Cardiomyocytes Undergoing Ischemia/Reperfusion by Stimulating PI3K-Akt-GSK3β Pathway and Preserving Mitochondrial Membrane Potential

Catestatin reduces myocardial ischaemia/reperfusion injury: involvement of PI3K/Akt, PKCs, mitochondrial KATP channels and ROS signalling

(2013) Maria-Giulia Perrelli et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Endothelium Dependent Cardiovascular Effects of the Chromogranin A-Derived Peptides Vasostatin-1 and Catestatin

(2012) S. Fornero et al.   CURRENT MEDICINAL CHEMISTRY

Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive catestatin

(2011) Tommaso Angelone et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

A novel catestatin-induced antiadrenergic mechanism triggered by the endothelial PI3K–eNOS pathway in the myocardium

(2011) Eleonora Bassino et al.   CARDIOVASCULAR RESEARCH

Is It Time to Translate Ischemic Preconditioning’s Mechanism of Cardioprotection into Clinical Practice?

(2011) Michael V. Cohen et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Chromogranin peptides in brain diseases

(2011) Michael Willis et al.   JOURNAL OF NEURAL TRANSMISSION

The therapeutic potential of ischemic conditioning: an update

(2011) Derek J. Hausenloy et al.   Nature Reviews Cardiology

Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga364–384)

(2010) Nilima Biswas et al.   CELL AND TISSUE RESEARCH

Catestatin Improves Post-Ischemic Left Ventricular Function and Decreases Ischemia/Reperfusion Injury in Heart

(2010) Claudia Penna et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

The Neuropeptide Catestatin Acts As a Novel Angiogenic Cytokine via a Basic Fibroblast Growth Factor–Dependent Mechanism

(2010) Markus Theurl et al.   CIRCULATION RESEARCH

Direct Vasoactive Effects of the Chromogranin A (CHGA) Peptide Catestatin in HumansIn Vivo

(2010) Maple M. Fung et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Chromogranin A and the Autonomic System: Decomposition of Heart Rate Variability and Rescue by Its Catestatin Fragment

(2010) Nagendu B. Dev et al.   ENDOCRINOLOGY

Human catestatin peptides differentially regulate infarct size in the ischemic–reperfused rat heart

(2010) Bhawanjit K. Brar et al.   REGULATORY PEPTIDES

Role of sarcoplasmic reticulum in mitochondrial permeability transition and cardiomyocyte death during reperfusion

(2009) Marisol Ruiz-Meana et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory peptides for cardiovascular functions

(2009) K. B. Helle   CARDIOVASCULAR RESEARCH

Akt Increases Sarcoplasmic Reticulum Ca2+Cycling by Direct Phosphorylation of Phospholamban at Thr17

(2009) Daniele Catalucci et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Heritability and Genome-Wide Linkage in US and Australian Twins Identify Novel Genomic Regions Controlling Chromogranin A

(2008) Daniel T. O'Connor et al.   CIRCULATION

Cardioprotection

(2008) Gerd Heusch et al.   CIRCULATION

Does Inhibition of Glycogen Synthase Kinase Protect in Mice?

(2008) Elizabeth Murphy et al.   CIRCULATION RESEARCH

The Chromogranin A-Derived Vasostatins: New Players in the Endocrine Heart

(2008) B. Tota et al.   CURRENT MEDICINAL CHEMISTRY

The Antihypertensive Chromogranin A Peptide Catestatin Acts as a Novel Endocrine/Paracrine Modulator of Cardiac Inotropism and Lusitropism

(2008) Tommaso Angelone et al.   ENDOCRINOLOGY

The homologous rat chromogranin A1–64 (rCGA1–64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide

(2008) M. C. Cerra et al.   FASEB JOURNAL